Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker

@inproceedings{Snchez2010FeasibilityOT,
  title={Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker},
  author={V{\'i}ctor S{\'a}nchez},
  year={2010}
}
A method for detecting toxigenic Clostridium difficile (C. difficile) by strand-invasion based DNA amplification is provided, together with oligonucleotides, compositions and kits suitable for use in this method. 

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 312 CITATIONS, ESTIMATED 48% COVERAGE

Pre-Hypertension: Rationale for Pharmacotherapy

  • Current Hypertension Reports
  • 2013
VIEW 8 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Testing for carryover effects after cessation of treatments: a design approach

  • BMC Medical Research Methodology
  • 2016
VIEW 17 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Potential health impact and cost-effectiveness of drug therapy for prehypertension.

  • International journal of cardiology
  • 2017
VIEW 6 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2007
2019

CITATION STATISTICS

  • 13 Highly Influenced Citations

  • Averaged 17 Citations per year from 2017 through 2019